This inventor holds 27 USPTO granted patents and 1 published patent application and 24 EPO patents, primarily in Antiviral Compounds. Top assignees: Janssen Sciences Ireland Uc, Janssen R&d Ireland, Tibotec Pharmaceuticals Ltd.. Active years: 2008-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Andé, FR (2008 - 2018)
- Ande, FR (2016 - 2020)
Company Filing History:
12 out of 111 
6 out of 45 
6 out of 67 
Years Active: 2008-2020
Areas of Expertise:
Title: Jerôme Emile Georges Guillemont - Innovator in Antibacterial Compounds
Introduction
Jerôme Emile Georges Guillemont, based in Andé, France, is an accomplished inventor known for his significant contributions to the field of antibacterial compounds. With a remarkable portfolio of 27 patents, Guillemont has been at the forefront of innovative solutions aimed at combating bacterial infections.
Latest Patents
Among his latest patents, Guillemont has developed novel compounds known as antibacterial cyclopenta[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones. These inventions relate to compounds that inhibit the activity of the FabI enzyme, which play a crucial role in the treatment of bacterial infections. In addition to the compounds themselves, the patents cover pharmaceutical compositions that incorporate these novel compounds, as well as the chemical processes used to prepare them.
Career Highlights
Throughout his career, Jerôme Guillemont has made substantial contributions while working at notable institutions, including Janssen Sciences Ireland UC and Janssen R&D Ireland. His work at these companies has solidified his reputation as an expert in pharmaceutical development, focusing on breakthroughs in antibacterial therapies.
Collaborations
Guillemont has worked alongside esteemed colleagues, including David Francis Alain Lançois and Magali Madeleine Simone Motte. These collaborations have facilitated innovative research and development efforts, further enhancing the potential applications of his inventions in the pharmaceutical industry.
Conclusion
With his extensive experience and a proven track record of innovation, Jerôme Emile Georges Guillemont continues to be a pivotal figure in the development of antibacterial treatments. His dedication to advancing medical science through inventions and patents demonstrates his commitment to improving public health through effective and innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile